glp-1 receptor agonist and dpp-4 inhibitor combination contraindicated Drug mechanism of action of analogues, DPP-IV inhibitors, DPP-4 and GLP-1 Combination: Safety

doi: 10.1111/1753-0407.12198 172 RosenstockJSorliCHTrautmannMEMoralesCWendischUDaileyGet al

Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function

Though these drugs have been deemed effective in treating T2DM, the Food and Drug Administration (FDA) and some members of the scientific community have questioned the safety of these therapeutics relative to important cardiovascular endpoints

(2009a)

It facilitates and improves the use of both ingested nutritional calories and stored energy, accelerating fat-burning and controlling hunger

Similar content being viewed by others Introduction Type 2 diabetes mellitus (T2DM) and obesity pose a growing challenge to public health, with millions of people affected by these pathological conditions and socio-economic costs steadily increasing worldwide